Shlomo Yanai insider trades

Open-market stock purchases and sales by Shlomo Yanai, Director at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 28, 2012.

Recent trades

DateStockTradeValue
May 7, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
May 6, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
May 6, 2026PM Philip Morris International IncBought (not open market)$190K

Companies traded

  • AMRX Amneal Pharmaceuticals, Inc: other filings, last May 7, 2026
  • PM Philip Morris International Inc: other filings, last May 6, 2026
  • GRA W R Grace & Co: other filings, last Sep 22, 2021
  • CBM Cambrex Corp: 1 sale, last Dec 4, 2019
  • PDLI PDL Biopharma, Inc: other filings, last Jun 20, 2019
  • XELA Exela Technologies, Inc: other filings, last Jul 12, 2017
  • SGNT Sagent Pharmaceuticals, Inc: other filings, last Aug 29, 2016
  • PRGO PERRIGO Co plc: other filings, last May 19, 2016
  • PLX Protalix BioTherapeutics, Inc: other filings, last Jul 24, 2014

Get free alerts when Shlomo Yanai files a new trade →